The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.
uk.yahoo.com/news/oxford-covid-19-vaccine-trials-061709120.html
Relative values, becoming very introspective.